Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy
Authors:
Open Access
- 1 June 2022
- journal article
- research article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 13 (3) , 1248-1254
Abstract
Original Article Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy Haochen Wang, Weizhong Xiao, Yanjing Han, Shasha Cao, Zhiyuan Zhang, Guang Chen, Yuefeng Hu, Long JinKeywords
This publication has 16 references indexed in Scilit:
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2017
- Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patientsWorld Journal of Gastroenterology, 2015
- Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score AnalysesRadiology, 2013
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancerAnnals of Oncology, 2013
- Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer ModelMolecular Cancer Therapeutics, 2013
- A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid TumorsClinical Cancer Research, 2012
- Endostatin Inhibits Angiogenesis in Hepatocellular Carcinoma after Transarterial ChemoembolizationHepatogastroenterology, 2012
- Arterial Blood Supply of Hepatocellular Carcinoma and Histologic Grading: Radiologic-Pathologic CorrelationAmerican Journal of Roentgenology, 2008
- Chemoembolization for hepatocellular carcinomaGastroenterology, 2004
- The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.1997